Found 5 matching trials
A Clinical Study of V503 in Chinese Females Who Have Previously Received a Bivalent Human Papillomavirus (HPV) Vaccine (V503-108) PHASE3 Researchers want to learn if V503 (also called the 9-valent human papilloma...
Show More Location
Multiple Locations
Learn More & Join Trial
Efficacy, Immunogenicity, and Safety of V503 in Chinese Males (V503-052) PHASE3 This study will evaluate the efficacy, immunogenicity, and safety of 9-vale...
Show More Status
Active Not Recruiting
Location
Beijing Youan Hospital ( Site 0001)
Learn More & Join Trial
Efficacy, Immunogenicity, and Safety Study of V503 (9-valent Human Papillomavirus [9vHPV] Vaccine) in Japanese Males (V503-064) PHASE3 The purposes of this phase 3, double-blind, placebo-controlled clinical stu...
Show More Location
Umeyama Clinic ( Site 6406)
Learn More & Join Trial
Efficacy Against Oral Persistent Infection, Immunogenicity and Safety of the 9-valent Human Papillomavirus Vaccine (9vHPV) in Men Aged 20-45 Years (V503-049) PHASE3 The purpose of this study is to evaluate the efficacy, immunogenicity and s...
Show More Status
Active Not Recruiting
Location
Valley Clinical Trials Inc. ( Site 0002)
Learn More & Join Trial
A Study of V503, a 9-valent Human Papillomavirus (9vHPV) Vaccine in Females 12-26 Years of Age Who Have Previously Received GARDASIL™ (V503-006) PHASE3 This study will evaluate whether V503 (9vHPV vaccine), is well tolerated in...
Show More Location
Multiple Locations
Learn More & Join Trial